Elite Pharmaceuticals (ELTP) Gross Margin (2010 - 2026)
Elite Pharmaceuticals' Gross Margin came in at 41.75% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 25.96 percentage points from 67.71% a year earlier and down 9.23 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) Gross Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Gross Margin of 43.47%, down 12.32 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was 50.40%, up 2.70 percentage points from FY2025.
- Gross Margin carries a five-year change of +3.64 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Gross Margin was 47.70% in FY2025 (+1.15 pp), 46.55% in FY2024 (-2.04 pp), 48.58% in FY2023 (+2.72 pp) and 45.86% in FY2022 (-0.90 pp).
- The five-year range for quarterly Gross Margin is 38.75% (fiscal Q2 2026) to 67.71% (fiscal Q1 2026).
- Year-over-year, Gross Margin has declined for four consecutive quarters, with an average year-over-year change of -1.08 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in fiscal Q1 2026 (a gain of 22.64 percentage points), and the weakest in fiscal Q1 2027 (a drop of 25.96 percentage points).
- Business Quant data shows ELTP's Gross Margin at 50.98% (Q4 2026), 41.01% (Q3 2026) and 38.75% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 72.78% |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 41.75% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.75% |
| Mar 31, 2026 | 50.98% |
| Dec 31, 2025 | 41.01% |
| Sep 30, 2025 | 38.75% |
| Jun 30, 2025 | 67.71% |
| Mar 31, 2025 | 54.05% |
| Dec 31, 2024 | 42.60% |
| Sep 30, 2024 | 43.42% |
| Jun 30, 2024 | 45.07% |
| Mar 31, 2024 | 45.23% |
| Dec 31, 2023 | 45.31% |
| Sep 30, 2023 | 45.54% |
| Jun 30, 2023 | 52.90% |
| Mar 31, 2023 | 39.82% |
| Dec 31, 2022 | 53.18% |
| Sep 30, 2022 | 44.54% |
| Jun 30, 2022 | 52.10% |
| Mar 31, 2022 | 44.51% |
| Dec 31, 2021 | 44.77% |
| Sep 30, 2021 | 44.03% |
Elite Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();